One of the most interesting ideas to take the dieting industry by storm is the Glycemic Index. The index was compiled in the early 1980s at the University of Toronto and is a ranking system for carbohydrates based on their immediate effect on blood glucose levels. Carbohydrates that break down rapidly during digestion and are easily converted to glucose have the highest glycemic indexes. Those who break down slowly and gradually release glucose into the blood stream have a low index. The low glycemic index means that the body absorbs less sugars and starches from foods which fall into this category.

The GI Plan diet is based on the idea that it is better to eat plenty of foods with a low glycemic index because the steady and gradual release of glucose into the blood will provide energy for a longer time while keeping the feeling of hunger at bay. Foods with a high GI will make you feel full for a short while, but the feeling passes fast and you find yourself reaching for something to eat long before the next meal of the day comes around. The second part of the GI Plan diet is to combine the original glycemic index with a ranking based on the calorie content of each food.

Like other diets, this one is split into several phases. The initial two-week phase is built around eating 17 points worth of food per day for women and 22 for men. The points are based on both the amount of bad carbs and calories found in food. One of the good things about this diet is the liberty granted to users. As long as you stick to the number

Editorial Board
(Source: Primary Care Diabetes)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Contents
(Source: Primary Care Diabetes)
American Diabetes Association: Are You Surrounded by Risk?
ALEXANDRIA, VA (MARKET WIRE) To combat the growing diabetes epidemic, the American Diabetes Association is asking Americans -- "What will you do to Stop Diabetes? Know your risk." On March 23, the 22nd annual American Diabetes Association Alert Day(SM), the Association is encouraging people to join the Stop Diabetes movement by taking the Diabetes Risk Test (at stopdiabetes.com or 800-DIABETES) to find out if they are at risk for developing type 2 diabetes and how they can take action to prevent the disease. (Source: Market Wire - Pharmaceuticals and Biotech)
Potential new drug for type 2 diabetes
An experimental oral drug has lowered blood sugar levels and inflammation in mice with Type 2 diabetes, suggesting that the medication could someday be added to the arsenal of drugs used by millions of Americans with this disease, according to new research. (Source: ScienceDaily Headlines)
Soy Formula, Maternal Diabetes Linked To Daughters' Fibroids
RESEARCH TRIANGLE PARK, N.C. - Analysis of the 2010 National Institute of Environmental Health Sciences Sister Study data for predictors of early uterine fibroid diagnoses found that an increased risk is associated with being fed soy formula and prepregnancy maternal diabetes, according to research published online March 2 by Environmental Health Perspectives (118;3:375-381). Full story on lexis.com (Source: LexisNexis&#174; Mealey's&#8482; Emerging Toxic Torts Legal News)
Medtronic Receives FDA Approval for Industry's Most Advanced Integrated System for Diabetes Management
Next Generation Integrated System – MiniMed Paradigm&reg; REAL-Time Revel™ System – Incorporates Predictive Alerts to Help Patients More Tightly Control Diabetes MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE:MDT ) today announced it has received U... Devices, Endocrinology, FDAMedtronic, MiniMed Paradigm, insulin pump, glucose monitor (Source: HSMN NewsFeed)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
FDA approves Medtronic diabetes system
Medtronic Inc. on Wednesday said federal regulators have approved its diabetes-management system, which includes features such as predictive alerts that warn diabetics about possible high or low blood sugar. (MDT) (Source: bizjournals.com Health Care:Biotechnology headlines)
ACC: ACCORD May Bring Few Changes to Clinic
ATLANTA (MedPage Today) -- Practice as usual may be the order of the day in the wake of an ACCORD trial finding that there's no cardiovascular risk reduction from intensified lipid and blood pressure management among diabetic patients. (Source: MedPage Today Cardiovascular)
Resveratrol - A Miracle Anti-Aging Drug Or Not?
Imagine a wonder drug that could slow down the aging process, and potentially one day provide a cure for disease such as diabetes and cancer. (Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire)
ACCORD Lipid Study Brings New Hope To People With Type 2 Diabetes And Atherogenic Dyslipidemia Says International Academic Foundation
Cardiovascular risk can be reduced by an additional 31 percent in type 2 diabetes patients with atherogenic dyslipidemia, the common combination of elevated triglycerides (TG, 204 mg/dL or 2.3 mmol/L or higher) and low levels of high-density lipoprotein cholesterol (HDL-C, 34 mg/dL or 0.88 mmol/L or lower). This is achieved by adding fenofibrate to simvastatin... (Source: Cardiovascular / Cardiology News From Medical News Today)
Search For New Diabetes And Heart Disease Treatments Unresolved
Treatment with the anti-hypertensive drug valsartan (Diovan) led to a modest reduction in the development of type 2 diabetes but did not significantly reduce cardiovascular events in patients with impaired glucose tolerance, according to researchers at Duke University Medical Center and the University of Oxford... (Source: Hypertension News From Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
ACCORD Lipid Study Brings New Hope To People With Type 2 Diabetes And Atherogenic Dyslipidemia Says International Academic Foundation
Cardiovascular risk can be reduced by an additional 31 percent in type 2 diabetes patients with atherogenic dyslipidemia, the common combination of elevated triglycerides (TG, 204 mg/dL or 2.3 mmol/L or higher) and low levels of high-density lipoprotein cholesterol (HDL-C, 34 mg/dL or 0.88 mmol/L or lower). This is achieved by adding fenofibrate to simvastatin. Only 20 of these patients need to be treated for 5 years to prevent one cardiovascular event... (Source: Health News from Medical News Today)
Search For New Diabetes And Heart Disease Treatments Unresolved
Treatment with the anti-hypertensive drug valsartan (Diovan) led to a modest reduction in the development of type 2 diabetes but did not significantly reduce cardiovascular events in patients with impaired glucose tolerance, according to researchers at Duke University Medical Center and the University of Oxford. They jointly reported results at the American College of Cardiology meeting from the world's first study designed to find ways to control the progression to diabetes and cardiovascular disease in people at risk... (Source: Health News from Medical News Today)
Amylin, Lilly And Alkermes Receive Complete Response Letter From FDA For Exenatide Once Weekly Submission
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for BYDUREON? (exenatide for extended-release injectable suspension). In the complete response letter there are no requests for new pre-clinical or clinical trials... (Source: Health News from Medical News Today)
Amylin, Lilly And Alkermes Receive Complete Response Letter From FDA For Exenatide Once Weekly Submission
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for BYDUREON? (exenatide for extended-release injectable suspension)... (Source: Diabetes News From Medical News Today)
The Control Of Fatty Acid Uptake By Muscle Cells
A new study from the Swedish medical university Karolinska Institutet shows that the blood vessels and muscles of the heart can regulate the uptake of fatty acids that we ingest through meat, milk products and other food. The researchers behind the study have also identified the way in which regulation is governed by the muscles themselves. The results, which are published in the scientific journal Nature, open the way for new forms of treatment for pathological fat accumulation in the muscles which, in turn, increases the risk of type II (adult) diabetes and cardiovascular disease... (Source: Health News from Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
FDA Requests Additional Information Regarding AFREZZA? In Complete Response Letter To MannKind
MannKind Corporation (Nasdaq:MNKD) announced that it has received a Complete Response letter from the U.S. Food & Drug Administration (FDA) regarding the New Drug Application (NDA) for AFREZZA? (insulin human [rDNA origin]) Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes mellitus for the control of hyperglycemia. A Complete Response letter is issued by the FDA's Center for Drug Evaluation and Research when the review of a file is completed and questions remain that preclude the approval of the NDA in its current form... (Source: Health News from Medical News Today)
Minorities At Greater Risk For Kidney Disease
Certain ethnic minorities, including African Americans and Hispanics, are at a higher risk than the general population for developing potentially life-threatening chronic kidney disease (CKD) , which has been linked to higher rates of diabetes and high blood pressure, according to the National Kidney Foundation (NKF)... (Source: Health News from Medical News Today)
The Control Of Fatty Acid Uptake By Muscle Cells
A new study from the Swedish medical university Karolinska Institutet shows that the blood vessels and muscles of the heart can regulate the uptake of fatty acids that we ingest through meat, milk products and other food. The researchers behind the study have also identified the way in which regulation is governed by the muscles themselves... (Source: Diabetes News From Medical News Today)
FDA Requests Additional Information Regarding AFREZZA? In Complete Response Letter To MannKind
MannKind Corporation (Nasdaq:MNKD) announced that it has received a Complete Response letter from the U.S. Food & Drug Administration (FDA) regarding the New Drug Application (NDA) for AFREZZA? (insulin human [rDNA origin]) Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes mellitus for the control of hyperglycemia... (Source: Diabetes News From Medical News Today)
Minorities At Greater Risk For Kidney Disease
Certain ethnic minorities, including African Americans and Hispanics, are at a higher risk than the general population for developing potentially life-threatening chronic kidney disease (CKD) , which has been linked to higher rates of diabetes and high blood pressure, according to the National Kidney Foundation (NKF)... (Source: Urology / Nephrology News From Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Sales surge pushes Axis-Shield to profit
The diagnostic group said sales of its diabetes-testing Afinion machine rose by 72% in 2009 and announced that it had bought back the US marketing rights to the device (Source: FT.com - Drugs and Healthcare)
Publix Pharmacies Launch Free Metformin For Type II Diabetes Patients As New Diabetes Program Debuts
Publix Pharmacies launched the first phase of a new diabetes management system. The program is a multi-faceted program established to assist customers and associates living with diabetes in managing their medication, compliance, monitoring, education, nutrition and exercise. In its first phase, this one-of-a-kind program offers diabetic patients free medication, online resources and the benefit of knowledgeable pharmacists. At the core of the program is the free generic immediate-release metformin (500 mg, 850 mg or 1,000 mg) - the generic form of the drug Glucophage... (Source: Health News from Medical News Today)
Publix Pharmacies Launch Free Metformin For Type II Diabetes Patients As New Diabetes Program Debuts
Publix Pharmacies launched the first phase of a new diabetes management system. The program is a multi-faceted program established to assist customers and associates living with diabetes in managing their medication, compliance, monitoring, education, nutrition and exercise... (Source: Diabetes News From Medical News Today)
Difficulty trusting and reaching out to others may shorten diabetes patients' lives
(University of Washington) Being overly cautious or dismissive in relating to others, including health-care providers, may shorten the lives of people with diabetes. In a five-year study, diabetes patients who had a lower propensity to reach out to others had a higher mortality rate than those who felt comfortable seeking support. There are approaches that health-care professionals might try to improve collaboration with patients who have an independent relationship style. (Source: EurekAlert! - Social and Behavioral Science)
Staples for skin closure in surgery
(Source: BMJ Online First)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Shrinking budgets, improving care: Simplify processes and engage with patients
(Source: BMJ Online First)
Prevalence of the Metabolic Syndrome among rural original adults in NingXia, China
Background Metabolic syndrome (MS) is combination of medical disorders that increase people's risk for cardiovascular disease and diabetes mellitus. Little data exists on the prevalence of MS of rural original adults in Ningxia of China.Methods A cross-sectional survey method was used and the participants were interviewed by trained health workers under a structured questionnaire in rural of Ningxia in 2008. The number of research subjects was 1612. MS was defined by International Diabetes Federation IDF (2005).Results The age-adjusted prevalence of the metabolic syndrome was 11.8%, whereas ethnic-specific prevalence was 10.3% in Han ethnic group and 13.7% in Hui ethnic group. Components of MS and MS were more common in Hui ethnic group than Han ethnic group. The mean levels and prevalence...
Program opens girls&#8217; eyes to science
After Keisha Barreto saw many of her relatives suffer serious health issues, she knew she wanted to be a doctor. "My mother has diabetes, my uncle died from heart problems and there is cancer in my family," said Barreto, a high school junior. "If there's... (Source: OrlandoSentinel: Medical Research)
Association between physical activity and metabolic syndrome: a cross sectional survey in adolescents in Ho Chi Minh City, Vietnam
Conclusions: A more physically active lifestyle appears to be associated with a lower odds of metabolic syndrome in Vietnamese adolescents. Socio-economic status should be taken into account when planning interventions to prevent adolescent metabolic syndrome. (Source: BMC Public Health - Latest articles)
Study: No association between thiazolidinediones, diabetic macular edema
Read the full story on MD Consult: Study: No association between thiazolidinediones, diabetic macular edema (Source: MD Consult: News: Top Stories)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Wednesday 17 March
Hospitals should axe thousands of beds: Nearly 30,000 hospital beds in England should be axed to save money and improve care, according to the think-tank Reform. The study, Fewer Hospitals and More Competition says the NHS focus should move away from hospital treatment as more people suffer from conditions, such as diabetes, which can be treated at home. It says a quarter of beds could be axed to fund more personalised treatment. Tom Sandford, Director of RCN England said: “Simply slashing bed numbers without planning for the long term would be completely irresponsible”. (Source: Royal College of Nursing News Alert)
Early-life determinants of overweight and obesity: a review of systematic reviews
The aim of this paper was to review the evidence for early-life (from conception to 5 years of age) determinants of obesity. The design is review of published systematic reviews. Data sources included Medline, Embase, Web of Science, Cochrane Library, CINAHL, PsycINFO. Identification of 22 eligible reviews from a database of 12 021 independent publications. Quality of selected reviews assessed using the Assessment of Multiple Systematic Reviews score. Articles published after the reviews were used to confirm results. No review was classified as high quality, 11 as moderate and 11 as low. Factors associated with later overweight and obesity: maternal diabetes, maternal smoking, rapid infant growth, no or short breastfeeding, obesity in infancy, short sleep duration, (Source: Obesity Reviews...
Sernova Announces Interim Results From Key Preclincal Study With Its Proprietary Cell Pouch SystemTM
Sernova Corp. (TSX VENTURE:SVA) today reported interim results from a key porcine diabetes study evaluating the safety and efficacy of the Cell Pouch System?. Interim results, to be presented at the American Society of Artificial Internal Organs 56th Annual Conference, Baltimore, MD, May 27th-29th in a podium presentation, confirm that the Cell Pouch System? establishes a biological environment capable of preserving the functionality of therapeutic cells... (Source: Health News from Medical News Today)
Sernova Announces Interim Results From Key Preclincal Study With Its Proprietary Cell Pouch SystemTM
Sernova Corp. (TSX VENTURE:SVA) today reported interim results from a key porcine diabetes study evaluating the safety and efficacy of the Cell Pouch System?... (Source: Diabetes News From Medical News Today)
FDA eyes improvements for diabetics' glucose devices
GAITHERSBURG, Maryland (Reuters) - U.S. health regulators are taking a closer look at how well devices used by diabetics to monitor their blood sugars work, seeking possible changes for device makers to help make them more reliable. (Source: Reuters: Health)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
FDA Eyes Improvements for Diabetics' Glucose Devices
U.S. health regulators are taking a closer look at how well devices used by diabetics to monitor their blood sugars work, seeking possible changes for device makers to help make them more reliable. Source: Reuters Health Related MedlinePlus Pages: Diabetes, Diabetes Type 1, Medical Device Safety (Source: MedlinePlus Health News)
Leveraging leptin for type I diabetes? [Commentaries]
(Source: Proceedings of the National Academy of Sciences)
Feature Article: Leptin therapy in insulin-deficient type I diabetes [Medical_Sciences]
In nonobese diabetic mice with uncontrolled type 1 diabetes, leptin therapy alone or combined with low-dose insulin reverses the catabolic... (Source: Proceedings of the National Academy of Sciences)
PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid &#x03C9;-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease
Fatty liver disease is a common lipid metabolism disorder influenced by the combination of individual genetic makeup, drug exposure, and life-style choices that are frequently associated with metabolic syndrome, which encompasses obesity, dyslipidemia, hypertension, hypertriglyceridemia, and insulin resistant diabetes. Common to obesity related dyslipidemia is the excessive storage of hepatic fatty acids (steatosis), due to a decrease in mitochondria &#x03B2;-oxidation with an increase in both peroxisomal &#x03B2;-oxidation, and microsomal &#x03C9;-oxidation of fatty acids through peroxisome proliferator activated receptors (PPARs). How steatosis increases PPAR&#x03B1; activated gene expression of fatty acid transport proteins, peroxisomal and mitochondrial fatty acid &#x03B2;-oxidation an...
Old Arthritis Drug May Help Diabetics (CME/CE)
A drug widely used to treat joint pain improved blood glucose control in patients with type 2 diabetes, researchers said. (Source: MedPage Today Nephrology)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Type 2 Diabetes Study: Drugs Don't Cut Heart Disease Risk
New data suggest that aggressive drug treatments to reduce known heart-disease risk factors don't actually help Type 2 diabetes patients. Why? And what now? (Source: TIME.com: Top Science and Health Stories)
Mylan, Takeda Reach Agreement Over Diabetes Drugs
From Associated Press (March 16, 2010) PITTSBURGH -- Generic drug maker Mylan Inc. has reached settlement agreements with Japanese drug maker Takeda Pharmaceuticals over rights to launch generic versions of two Type 2 diabetes treatments. Mylan... (Source: Drugs.com - Pharma News)
Globe article on the cost of care at Children?s
A Boston Globe article this morning brought the cost of care here at Children?s Hospital Boston into question, saying, among other things, that ?Children?s charges the highest fees for both outpatient and inpatient care.? It?s based on data by Harvard Pilgrim Health Care (HPHC) that we don?t feel accurately reflects the care that we provide. While the writer, Liz Kowalczyk, did say that because about 30 percent of our patients are on Medicaid, we have to ?make up the lost revenue from private insurers,? I don?t think she went far enough in explaining why our costs tend to be higher than other hospitals in the state. First and most important, Children?s is the only freestanding children?s hospital on the Globe?s list, so comparing the care we deliver to that of hospi...
Valsartan delays progression to type 2 diabetes
Results from a landmark study involving more than 9,000 people showed that the high blood pressure medicine valsartan delayed progression to type 2 diabetes in patients with cardiovascular disease or risk factors and impaired glucose tolerance (IGT). (Source: Pharmacy Europe)
Obesity and lung inflammation
The prevalence of obesity has increased dramatically worldwide, predisposing individuals to an increased risk of morbidity and mortality due to cardiovascular disease and type 2 diabetes. Less recognized is the fact that obesity may play a significant role in the pathogenesis of pulmonary diseases through mechanisms that may involve proinflammatory mediators produced in adipose tissue that contribute to a low-grade state of systemic inflammation. In animal models, inflammatory responses in the lung have been shown to influence the production of the adipocytokines, leptin and adiponectin, cytokines, acute phase proteins, and other mediators produced by adipose tissue that may participate in immune responses of the lung. An increased adipose tissue mass may also influence susceptibility to p...<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Study shows superior efficacy for Taxus Express Stents at one year compared to bare-metal stents in diabetic patients experiencing heart attack
Boston Scientific applies to FDA for expanded indications for TAXUS Express and TAXUS(R) Liberte(R) Stents in AMI patients NATICK, Mass. and ATLANTA, March 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced results... (Source: Drugs.com - Clinical Trials)
BES: Testosterone Gel Improves Diabetes in Hypogonadal Men (CME/CE)
MANCHESTER, England (MedPage Today) -- Topical testosterone replacement reduced insulin resistance and glycated hemoglobin in men who were deficient in the hormone and at risk for, or diagnosed with type 2 diabetes, researchers reported here. (Source: MedPage Today Cardiovascular)
Generex Oral-lyn(TM) Presentation at CODHy Congress
WORCESTER, Mass., March 16, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that Philip Raskin, MD, of The University of Texas Southwestern Medical Center in Dallas, Texas, made a presentation in respect of Generex Oral-lyn(tm), the Company's proprietary buccal insulin spray product, at The Latin America Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) held in Buenos Aires, Argentina, March 11-14, 2010 (www.comtecmed.com/Codhy/argentina). (Source: Medical News (via PRIMEZONE))
New Research Reveals Potential New Drug For Type 2 Diabetes
An experimental oral drug has lowered blood sugar levels and inflammation in mice with Type 2 diabetes, suggesting that the medication could someday be added to the arsenal of drugs used by millions of Americans with this disease, according to new research. The drug consists of a synthetic molecule that stops the biological activity of a protein called macrophage migration inhibitory factor, or MIF. This protein is implicated in a number of diseases because it is associated with the production of inflammation in the body... (Source: Health News from Medical News Today)
More Support For Health Benefits Of Coffee
Multitudes of people worldwide begin each day with a cup of steaming hot coffee. Although it is sometimes referred to as "the devil's brew," coffee contains several nutrients (eg, calcium) as well as hundreds of potentially biologically active compounds (eg, polyphenols) that may promote health. For instance, observational studies have suggested a beneficial link between coffee consumption and type 2 diabetes. Determining whether or not this association is causative, however, requires controlled intervention trials... (Source: Health News from Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
New Research Reveals Potential New Drug For Type 2 Diabetes
An experimental oral drug has lowered blood sugar levels and inflammation in mice with Type 2 diabetes, suggesting that the medication could someday be added to the arsenal of drugs used by millions of Americans with this disease, according to new research... (Source: Biology / Biochemistry News From Medical News Today)
Diabetes Trial: Drug Treatment May Not Cut Heart Disease
New data suggest that aggressive drug treatments to reduce known heart-disease risk factors don't actually help diabetes patients. Why? And what now? (Source: TIME.com: Top Science and Health Stories)
Diabetes' link to eating disorders explored
Diabetics, under the gun to better manage their disease by controlling their food intake and weight, may find themselves in the sticky wicket of needing treatment that makes them hungry, researchers said. (Source: ScienceDaily Headlines)
Partners reducing effects of diabetes (PREDICT): a diabetes prevention physical activity and dietary intervention through African-American churches
Type 2 diabetes is epidemic in the United States with greater incidence rates in African-American communities. Lifestyle interventions during the phase of insulin resistance mitigate cardiovascular risk and prevent diabetes. The primary aim of this study is to test the impact of a Community Health Advisor (CHA)-based diabetes prevention controlled intervention in urban African-American communities. In this controlled trial, church congregants in New Haven, CT, receiving a 1-year CHA-led diabetes prevention intervention were compared with church congregants in Bridgeport, CT, who did not receive an intervention. Outcome measures included physical activity, dietary pattern, anthropometric measure, social support, diabetes knowledge, nutrition and exercise self-efficacy. The results indicate ...
The role of collective efficacy in exercise adherence: a qualitative study of spousal support and Type 2 diabetes management
Adhering to increased exercise is often reported as one of the greatest challenges facing adults living with diabetes, a perception shared by the married middle-aged and older adults living with diabetes who participated in this study. Understanding how that challenge can best be met is both research and program relevant. Drawing on the social cognitive theory and social support literature, this qualitative study explored the powerful couple relationship in Type 2 diabetes management. The overarching goal of this paper was to illuminate the potentially key role of collective efficacy in exercise adherence in order to develop and test interventions that provide more effective supports for adults living with diabetes. Analyses revealed three core themes used by the couples to describe their ...<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Lifestyle And Diet Still Best Ways To Help Prevent Type 2 Diabetes
Researchers looking at whether using a drug that lowers blood pressure (Valsartan) or a drug that lowers blood glucose levels (Nateglinide) could prevent Type 2 diabetes from developing found no great difference in the number of people who went on to develop the condition when prescribed either drug compared with the people who were prescribed a dummy pill. The drugs were also not successful in preventing heart attacks and strokes, which are complications of Type 2 diabetes. All the people taking part in the study had high blood glucose levels... (Source: Health News from Medical News Today)
Study Shows Superior Efficacy For TAXUS(R) Express(R) Stents At One Year Compared To Bare-Metal Stents In Diabetic Patients Experiencing Heart Attack
Boston Scientific Corporation (NYSE: BSX) announced results from an analysis of one-year subset data from the HORIZONS AMI trial assessing the impact of diabetes on clinical and angiographic outcomes in heart attack patients treated with the TAXUS® Express2? Paclitaxel-Eluting Stent System or the Express® bare-metal stent... (Source: Health News from Medical News Today)
Generic Drug For Type 2 Diabetes Passes Next Clinical Hurdle
Clinical studies of a generic drug called salsalate, widely prescribed for arthritis, now provide early promising results that it may be useful for the treatment of patients with type 2 diabetes as well. Salsalate is an atypical non-steroidal anti-inflammatory agent that is chemically similar to aspirin but a bit easier on the stomach. In a three-month trial of people with type 2 diabetes that was led by Joslin Diabetes Center researchers, those who took the drug showed significantly improved blood glucose levels... (Source: Health News from Medical News Today)
Lifestyle And Diet Still Best Ways To Help Prevent Type 2 Diabetes
Researchers looking at whether using a drug that lowers blood pressure (Valsartan) or a drug that lowers blood glucose levels (Nateglinide) could prevent Type 2 diabetes from developing found no great difference in the number of people who went on to develop the condition when prescribed either drug compared with the people who were prescribed a dummy pill... (Source: Diabetes News From Medical News Today)
Study Shows Superior Efficacy For TAXUS(R) Express(R) Stents At One Year Compared To Bare-Metal Stents In Diabetic Patients Experiencing Heart Attack
Boston Scientific Corporation (NYSE: BSX) announced results from an analysis of one-year subset data from the HORIZONS AMI trial assessing the impact of diabetes on clinical and angiographic outcomes in heart attack patients treated with the TAXUS® Express2? Paclitaxel-Eluting Stent System or the Express® bare-metal stent... (Source: Diabetes News From Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Generic Drug For Type 2 Diabetes Passes Next Clinical Hurdle
Clinical studies of a generic drug called salsalate, widely prescribed for arthritis, now provide early promising results that it may be useful for the treatment of patients with type 2 diabetes as well. Salsalate is an atypical non-steroidal anti-inflammatory agent that is chemically similar to aspirin but a bit easier on the stomach... (Source: Diabetes News From Medical News Today)
Researcher urges caution in reducing blood pressure
For patients with diabetes and heart disease, less isn't always more &#8212; at least when it comes to blood pressure. New data show an increased risk of heart attack, stroke or death for patients having blood pressure deemed too high &#8212; or too low,... (Source: OrlandoSentinel: Medical Research)
UNC's Dr. John Buse To Receive National Award For Clinical Excellence
John B. Buse, M.D., Ph.D., has been selected to receive a Clinical Excellence award at the Castle Connolly National Physician of the Year Awards ceremony. Buse is a professor in the University of North Carolina at Chapel Hill School of Medicine, chief of the division of endocrinology and metabolism and director of the UNC Diabetes Care Center... (Source: Health News from Medical News Today)
Mayo Clinic Proceedings Study Finds Link Between Hypoglycemia And Mortality Rates In Critically Ill
In a study published in the March issue of Mayo Clinic Proceedings, researchers report that they have found a link between mild to moderate hypoglycemia (low blood sugar) and mortality in critically ill patients. The multicenter study involved six medical centers from Australia, New Zealand and Japan. The purpose of the study was to understand the epidemiology, severity, duration, recovery and outcome associations of hypoglycemia in critically ill patients... (Source: Health News from Medical News Today)
Mayo Clinic Proceedings Study Finds Link Between Hypoglycemia And Mortality Rates In Critically Ill
In a study published in the March issue of Mayo Clinic Proceedings, researchers report that they have found a link between mild to moderate hypoglycemia (low blood sugar) and mortality in critically ill patients. The multicenter study involved six medical centers from Australia, New Zealand and Japan... (Source: Diabetes News From Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
UNC's Dr. John Buse To Receive National Award For Clinical Excellence
John B. Buse, M.D., Ph.D., has been selected to receive a Clinical Excellence award at the Castle Connolly National Physician of the Year Awards ceremony. Buse is a professor in the University of North Carolina at Chapel Hill School of Medicine, chief of the division of endocrinology and metabolism and director of the UNC Diabetes Care Center... (Source: Public Health News From Medical News Today)
Salsalate May Help Treat Type 2 Diabetes
Title: Salsalate May Help Treat Type 2 DiabetesCategory: Health NewsCreated: 3/16/2010 10:27:00 AMLast Editorial Review: 3/16/2010 10:27:48 AM (Source: MedicineNet Diabetes General)
ED, Heart Disease May Be Deadly Duo
Title: ED, Heart Disease May Be Deadly DuoCategory: Health NewsCreated: 3/16/2010 9:59:00 AMLast Editorial Review: 3/16/2010 9:59:28 AM (Source: MedicineNet Diabetes General)
Boosting Vitamin D Can Do a Heart Good
Title: Boosting Vitamin D Can Do a Heart GoodCategory: Health NewsCreated: 3/15/2010 4:10:00 PMLast Editorial Review: 3/16/2010 (Source: MedicineNet Diabetes General)
Salsalate May Help Treat Type 2 Diabetes
Title: Salsalate May Help Treat Type 2 DiabetesCategory: Health NewsCreated: 3/16/2010 10:27:00 AMLast Editorial Review: 3/16/2010 10:27:48 AM (Source: MedicineNet Senior Health General)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Salsalate May Help Treat Type 2 Diabetes
(Source: eMedicineHealth.com)
Vital Signs: Study Links Soda Price Increases to Better Health
Research found that when the price of a two-liter bottle went up, people consumed less, which was associated with a drop in weight and a lower risk for pre-diabetes. (Source: NYT)
Landmark ACCORD Trial Finds Intensive Blood Pressure and Combination Lipid Therapies do not Reduce Combined Cardiovascular Events in Adults with Diabetes
Source: National Heart, Lung, and Blood Institute - Related MedlinePlus Page: Diabetes Complications (Source: MedlinePlus Health News)
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
Boston Scientific applies to FDA for expanded indications for TAXUS Express and TAXUS(R) Liberte(R) Stents in AMI patients NATICK, Mass. and ATLANTA, March 15 (HSMN NewsFeed) -- Boston Scientific Corporation (NYSE:BSX ) today announced results from an... Devices, Interventional CardiologyBoston Scientific, TAXUS Express2, drug eluting stent, bare-metal stent (Source: HSMN NewsFeed)
Socio-economic differences in life expectancy among persons with diabetes mellitus or myocardial infarction: results from the German MONICA/KORA study
Conclusion: This study shows that in Germany the differences in LE by socio-economic status are comparable to those found in other European countries, and that these differences seem to increase when diabetes mellitus or myocardial infarction are present. The statistical method used allows estimates of LE with relatively small datasets. (Source: BMC Public Health - Latest articles)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
No benefit of lower blood pressure or lipid targets in type 2 diabetes
Read the full story on MD Consult: No benefit of lower blood pressure or lipid targets in type 2 diabetes (Source: MD Consult: News: Top Stories)
Drugs in type 2 diabetes: their properties and recommended use
There are now six classes of oral antidiabetic drugs and a new class of injectable GLP-1 agonists in the drug therapy of type 2 diabetes, with metformin remaining the cornerstone of treatment. Our Drug review considers their mode of action, properties and recommended use, followed by sources of further information and an analysis of prescription data. Copyright © 2010 Wiley Interface Ltd (Source: Prescriber)
Pluripotent plasticity of stem cells and liver repopulation
Different types of stem cells have a role in liver regeneration or fibrous repair during and after several liver diseases. Otherwise, the origin of hepatic and/or extra-hepatic stem cells in reactive liver repopulation is under controversy. The ability of the human body to self-repair and replace the cells and tissues of some organs is often evident. It has been estimated that complete renewal of liver tissue takes place in about a year. Replacement of lost liver tissues is accomplished by proliferation of mature hepatocytes, hepatic oval stem cells differentiation, and sinusoidal cells as support. Hepatic oval cells display a distinct phenotype and have been shown to be a bipotential progenitor of two types of epithelial cells found in the liver, hepatocytes, and bile ductular cells. In g...
Mitigation of septic shock in mice and rhesus monkeys by human chorionic gonadotrophin-related oligopeptides
The marked improvement of several immune-mediated inflammatory diseases during pregnancy has drawn attention to pregnancy hormones as potential therapeutics for such disorders. Low molecular weight fractions derived from the pregnancy hormone human chorionic gonadotrophin (hCG) have remarkable potent immunosuppressive effects in mouse models of diabetes and septic shock. Based on these data we have designed a set of oligopeptides related to the primary structure of hCG and tested these in models of septic shock in mice and rhesus monkeys. We demonstrate that mice exposed to lipopolysaccharide (LPS) and treated subsequently with selected tri-, tetra-, penta- and hepta-meric oligopeptides (i.e. MTR, VVC, MTRV, LQGV, AQGV, VLPALP, VLPALPQ) are protected against fatal LPS-induced septic shock....
Salsalate for blood glucose control?
Source: Ann Intern Med Area: News A small controlled trial suggests that salsalate, a derivative of salicylic acid that acts as a salicylate pro-drug, may improve blood glucose control in type 2 diabetes. &nbsp; There is some experimental evidence that salicylate may improve glycaemic control in type 2 diabetes: this trial aimed to determine what dose of salsalate, a salicylate pro-drug with no gastro-intestinal irritant effects, was beneficial in such patients. Participants were adults with type 2 diabetes: inclusion criteria were fasting plasma glucose concentrations of 12.5 mmol/L or less and haemoglobin A1c (HbA1c) levels of 7.0% to 9.5%, treated by diet, exercise, and oral medication at stable doses for at least 8 weeks. They were randomised to salsalate 3.0, 3.5, or 4.0 gm daily...<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Dapagliflozin improves glycemic control and weight of Type 2 diabetics
Study results show that dapagliflozin treatment improves the glycemic control and body weight of both early and late-stage Type 2 diabetics. (Source: MedWire News - Diabetes)
[Research Article] Cholinergic Augmentation of Insulin Release Requires Ankyrin-B
The scaffolding protein ankyrin-B is needed for maximal insulin release and loss of function is a risk factor for diabetes. (Source: Signal Transduction Knowledge Environment)
Salsalate May Help Treat Type 2 Diabetes
Salsalate, a common pain reliever, may help people with type 2 diabetes control their blood sugar levels. (Source: WebMD Health)
Observatory: Seeking Safe Ways to Deliver Nitric Oxide in Medical Care
Researchers are investigating new methods for storing and releasing an important gas for those who do not produce enough of it. (Source: NYT &gt; Health)
To Cut Diabetes Heart Risks, Diet and Exercise May Beat Drugs
A 5-step action plan for lowering heart risks associated with diabetes. (Source: U.S. News - Health)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Salsalate As a Type 2 Diabetes Treatment? It Looks Promising
A longtime arthritis medicine could one day be an affordable diabetes treatment. (Source: U.S. News - Health)
Drug Helps Diabetics, Trial Finds
A generic anti-inflammatory drug from the aspirin family helped patients in a clinical trial lower their blood sugar. (Source: NYT &gt; Health)
Arthritis Drug May Fight Diabetes, Too
Study finds that salsalate helps control blood sugar levels Source: HealthDay Related MedlinePlus Pages: Arthritis, Diabetes, Medicines (Source: MedlinePlus Health News)
Adding fat-lowering drug no help for diabetic hearts
ATLANTA (Reuters) - Adding a drug that lowers blood fats known as triglycerides to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study. (Source: Reuters: Health)
Boosting Vitamin D Can Do a Heart Good
In those with low levels to start, odds eased for diabetes, cardio woes, study found Source: HealthDay Related MedlinePlus Pages: Heart Diseases--Prevention, Vitamin D (Source: MedlinePlus Health News)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Vital Signs: Study Links Soda Price Increases to Better Health
Research found that when the price of a two-liter bottle went up, people consumed less, which was associated with a drop in weight and a lower risk for pre-diabetes. (Source: NYT &gt; Health)
Adding Fat-Lowering Drug No Help for Diabetic Hearts
Adding a drug that lowers blood fats known as triglycerides to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study.Source: Reuters Health Related MedlinePlus Pages: Diabetes, Heart Diseases, Statins (Source: MedlinePlus Health News)
Ezetimibe Reduces Hepatic Fat in Obese Patients
In insulin-resistant subjects on a weight loss diet, ezetimibe (Zetia) reduces hepatic steatosis and inflammatory markers, Australian researchers report in the February 25th online issue of Diabetes Care. Reuters Health Information (Source: Medscape Diabetes Headlines)
Exenatide Improves Postprandial Endothelial Function
The diabetes drug exenatide (Byetta) is known to lower glucose and is believed to lower lipid excursions after meals, but new research suggests that it may also improve endothelial function. Reuters Health Information (Source: Medscape Diabetes Headlines)
ACC: Saline, Bicarb Tie for Kidney Safety (CME/CE)
ATLANTA (MedPage Today) -- Sodium bicarbonate hydration appears no better than the old standard, saline, in preventing kidney damage from use of radiology contrast agents in at-risk diabetes patients, according to one of the first head-to-head comparison trials. (Source: MedPage Today Cardiovascular)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
ACCORD on Lipids, Blood Pressure in Diabetics, Mitral-clip May Rival Surgery, CV Risk in Prediabetics, Psoriasis and CV Disease
Join Dr. Melissa Walton-Shirley for a review of the latest cardiology trials from ACC 2010: ACCORD, EVEREST II, NAVIGATOR, and more. Medscape Cardiology (Source: Medscape Today Headlines)
Alkermes shares pop on FDA's diabetes-drug response
Alkermes Inc. shares popped Monday on news that federal regulators responded positively to a new diabetes-drug application filed by the Waltham, Mass.-based biotechnology firm and its development partners, Amylin Pharmaceuticals Inc. and Eli Lilly and Co. (LLY) (Source: bizjournals.com Health Care:Biotechnology headlines)
Factors associated with probability of personal digital assistant-based dietary self-monitoring in those with type 2 diabetes
This study examined modifiable and nonmodifiable factors associated with technology-based self-monitoring. 123 participants with type 2 diabetes self-monitored diet using a personal digital assistant in a 6-month behavioral intervention. Multinomial logistic regression was used to examine probability of nonadherent and suboptimally adherent behavior relative to adherent behavior. Sociodemographic characteristics were not associated with probability of self-monitoring. Probability of adherence generally was greater in the weeks preceding no group session, and lower in the weeks following no group session or following skipped sessions. Non-modifiable factors suggested by the literature to be associated with poorer access to technology (lower income, older age, minority race, and lower ...
Possible cause of failure after McCall culdoplasty
Conclusion&nbsp;&nbsp;Failure of McCall culdoplasty occurs more frequently in patients with history of vaginal delivery of macrosomic infants, possibly due to direct pelvic floor damage. This technique should not be used in patients with a possible history of direct pelvic floor damage. Content Type Journal ArticleCategory General GynecologyDOI 10.1007/s00404-010-1418-0Authors Cetin Cam, Zeynep Kamil Hospital Department of Obstetrics and Gynecology No: 1, Selimiye, Uskudar 34668 Istanbul TurkeyAtes Karateke, Zeynep Kamil Hospital Department of Obstetrics and Gynecology No: 1, Selimiye, Uskudar 34668 Istanbul TurkeyMehmet Resit Asoglu, Zeynep Kamil Hospital Department of Obstetrics and Gynecology No: 1, Selimiye, Uskudar 34668 Istanbul TurkeySelcuk Selcuk, Zeynep Kamil Hospital...
Publix launches new diabetes program
Publix Pharmacies launched the first phase of a new diabetes management system March 15, which offers diabetic patients free medication. (Source: bizjournals.com Health Care:Biotechnology headlines)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
NGM closes 1st tranche of $51M round
NGM Biopharmaceuticals closed the first tranche of a $51 million Series B financing, with plans to funnel the cash into diabetes treatments. (Source: bizjournals.com Health Care:Biotechnology headlines)
ACCORD lipid: Fibrates do not improve CV outcomes in diabetic patients taking statins
Combination therapy with fenofibrate and simvastatin does not provide additional protection against cardiovascular disease in high-risk patients with Type 2 diabetes compared with simvastatin alone, according to findings from the ACCORD lipid trial. (Source: MedWire News - Lipidology)
Novel therapeutic concepts * The epidemic of cardiovascular disease in the developing world: global implications
The epidemic of cardiovascular disease (CVD) is a global phenomenon, and the magnitude of its increase in incidence and prevalence in low- and middle-income countries (LIMIC) has potentially major implications for those high-income countries that characterize much of the developed world. Cardiovascular disease remains the leading cause of death in the world and approximately 80% of all cardiovascular-related deaths occur in LIMIC and at a younger age in comparison to high-income countries. The economic impact in regard to loss of productive years of life and the need to divert scarce resources to tertiary care is substantial. The &lsquo;epidemiologic transition&rsquo; provides a useful framework for understanding changes in the patterns of disease as a result of societal and socioeconomic ...
Comparison of health-related measures of two groups of adolescents in a rural southeastern county in the United States
Conclusion Thus, this research shows differences between similar populations in the same county and these differences must be explored further. (Source: Health Education Journal)
Behavioural change in type 1 diabetes self-management: Why and how?
Conclusions Individuals intensively self-managing their diabetes have a high degree of motivation to improve glycaemic control, but also require the assistance of health professionals in primary and secondary care to enable this to take place. (Source: Health Education Journal)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Body's anticipation of a meal can be a diabetes risk factor
Alterations in our response to the taste or smell of food may be another culprit responsible for Type 2 diabetes, according to scientists who have identified the specific mechanism in human specimens and in mice. (Source: ScienceDaily Headlines)
Search for Better Diabetes Therapy Falls Short
New strategies to prevent and treat diabetes and heart disease failed to improve care in two major studies, frustrating researchers' efforts to find more-effective approaches to the world's burgeoning diabetes epidemic. (Source: RWJF News Digest - Quality/Equality)
Rhythm Pharma launches, raises $21M
Rhythm Pharmaceuticals Inc., a developer of peptide-based drugs to treat conditions such as obesity and diabetes, has launched with a $21 million Series A round of funding. The round was led by Boston?s MPM Capital and New Enterprise Associates of Maryland. (Source: bizjournals.com Health Care:Biotechnology headlines)
Landmark Accord Trial Finds Intensive Blood Pressure and Combination Lipid Therapies do not Reduce Combined Cardiovascular Events in Adults with Diabetes
BETHESDA, Md.,&nbsp;March 15, 2010--&nbsp;Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2... (Source: Drugs.com - Clinical Trials)
FDA letter moves Amylin drug toward approval
Amylin Pharmaceuticals, and partners Eli Lilly & Co. and Alkermes Inc., said Monday that their exenatide diabetes treatment is moving closer to approval by the Food and Drug Administration. (AMLN) (LLY) (Source: bizjournals.com Health Care:Biotechnology headlines)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Academia is still not doing enough to make UK a leader in research
(Source: BMJ Online First)
Diabetes Drug From Lilly, Amylin Under Scrutiny
FDA asks for more detail on labeling of Bydureon, pharmaceutical firms' shares show little impact. (Source: PharmaManufacturing.com)
Protective and Anticataract Effects of the Aqueous Extract of Cleistocalyx operculatus Flower Buds on ?-Cells of Streptozotocin-Diabetic Rats
Journal of Agricultural and Food Chemistry, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable). (Source: Journal of Agricultural and Food Chemistry)
ACCORD lipid: Fibrates do not improve CV outcomes in diabetic patients taking statins
Combination therapy with fenofibrate and simvastatin does not provide additional protection against cardiovascular disease in high-risk patients with Type 2 diabetes compared with simvastatin alone, according to findings from the ACCORD lipid trial. (Source: MedWire News - Diabetes)
Landmark ACCORD Trial Finds Intensive Blood Pressure and Combination Lipid Therapies do not Reduce Combined Cardiovascular Events in Adults with Diabetes
Lowering blood pressure to normal levels -- below currently recommended levels -- did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial. Similarly, treating multiple blood lipids with combination drug therapy of a fibrate and a statin did not reduce the combined risk of cardiovascular disease events more than treatment with statin alone. The study of more than 10,000 participants is sponsored by the National Institutes of Health. (Source: National Institutes of Health (NIH) News Releases)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Blood Pressure Drugs No Help for Diabetes
Studies: Statins, Fibrates to Lower Fats, Cholesterol and Blood Pressure Do Not Reduce Heart Attack Risk in Diabetics (Source: Health News: CBSNews.com)
Blood Pressure Drugs No Help for Diabetes
Studies: Statins, Fibrates to Lower Fats, Cholesterol and Blood Pressure Do Not Reduce Heart Attack Risk in Diabetics (Source: Health News: CBSNews.com)
Blood Pressure Drugs No Help for Diabetes
Studies: Statins, Fibrates to Lower Fats, Cholesterol and Blood Pressure Do Not Reduce Heart Attack Risk in Diabetics (Source: Health News: CBSNews.com)
ACCORD BP: Intensive BP control does not benefit diabetic patients at high CV risk
Intensive blood pressure control does not reduce the rate of cardiovascular events in patients with Type 2 diabetes and high CV risk, reveals research presented at the 59th Annual Scientific Sessions of the American College of Cardiology in Atlanta, Georgia, USA. (Source: MedWire News - Hypertension)
ACCORD lipid: Fibrates do not improve CV outcomes in diabetic patients taking statins
Combination therapy with fenofibrate and simvastatin does not provide additional protection against cardiovascular disease in high-risk patients with Type 2 diabetes compared with simvastatin alone, according to findings from the ACCORD lipid trial. (Source: MedWire News - Cardiology)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Intensive Blood Pressure Control, Fenofibrate Lipid Therapy Not Justified in High-Risk Diabetics
(Source: Physician's First Watch current issue)
Nateglinide, Valsartan Have Little Effect on Preventing Diabetes or Cardiovascular Events
(Source: Physician's First Watch current issue)
FDA Asks for Risk Plan Info on Diabetes Drug
From Associated Press (March 15, 2010) SAN DIEGO -- Amylin Pharmaceuticals Inc. said Monday it received a Food and Drug Administration request for information on manufacturing and a risk mitigation plan for a potential once-weekly diabetes... (Source: Drugs.com - Pharma News)
Novartis International AG (CH) - NAVIGATOR Shows valsartan Delayed Progression to type 2 diabetes in at-risk Cardiovascular Patients with Impaired Glucose Tolerance
*NAVIGATOR study involved more than 9,000 patients, making it one of the largest and longest global trials to date in pre-diabetic patients * Valsartan-based regimen reduced risk of developing new-onset diabetes by 14%, but did not reduce risk... (Source: Drugs.com - Clinical Trials)
Drugs for halting diabetes tested
Conclusion Overall, this large, industry-funded study found that nateglinide had no effect on the incidence of diabetes or cardiovascular disease in this population and that valsartan had a small effect on diabetes risk but not on cardiovascular outcomes. This was well-conducted research and used the most robust study design for comparing the effectiveness of one treatment with another. There are some points to highlight, including the fact that 20% of participants in each trial arm dropped out of the study (they either withdrew their participation, died or were lost in the follow-up). Other important points relating to the research and its interpretation are raised in an accompanying editorial in the journal, written by Dr. David Nathan from the Diabetes Centre at Harvard Medical School. ...<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Enhancing Excellence in Endocrinology (E3) ? Senior Leaders
Enhancing Excellence in Endocrinology (E3) is delighted to announce that registration is now open for the next advanced communications and management skills training course &#8211; Senior Leaders &#8211; which will be held on 14&#8211;15 October 2010 at the University of Warwick Conference Centre. Designed for consultants in adult or paediatric endocrinology who have been in their consultant post for at least 5 years, this 2-day bespoke high level training experience is delivered by leading professionals and communication and business skills trainers. The course will address the challenges you may face in your senior role allowing you to: enhance your leadership and organisational development skills; have a better understanding of your team and core communication skills; enhance your busi...
Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use
&nbsp; ATLANTA, March 14 /PRNewswire-FirstCall/ -- Results were presented today on behalf of the National Heart, Lung and Blood Institute from ACCORD, a study in patients with diabetes that evaluated cardiovascular outcomes in three distinct studies... (Source: Drugs.com - Clinical Trials)
Diabetes drugs 'ineffective'
Tests on two Novartis-made diabetes drugs have concluded that both have little or no effect on the condition, it has been revealed. (Source: Nursing Times Breaking News)
Hormonal Therapy and Sex Reassignment: A Systematic Review and Meta-analysis of Quality of Life and Psychosocial Outcomes
What is the prognosis of individuals with gender identity disorder receiving hormonal therapy as a part of sex reassignment, in terms of quality of life and other self-reported psychosocial outcomes? Clinical Endocrinology (Source: Medscape Today Headlines)
Ranbaxy to launch anti-diabetic drug Actos by 2012
Pharma major Ranbaxy Laboratories Friday said it will launch anti-diabetic drug Actos in the US by 2012. (Source: The Economic Times Healthcare and Biotech News)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines For Fibrate Use
Results were presented today on behalf of the National Heart, Lung and Blood Institute from ACCORD, a study in patients with diabetes that evaluated cardiovascular outcomes in three distinct studies - glycemic control, blood pressure control and lipid control... (Source: Cardiovascular / Cardiology News From Medical News Today)
Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines For Fibrate Use
Results were presented today on behalf of the National Heart, Lung and Blood Institute from ACCORD, a study in patients with diabetes that evaluated cardiovascular outcomes in three distinct studies - glycemic control, blood pressure control and lipid control. In response to data from the ACCORD Lipid study, Abbott issued the following statement: "The results of ACCORD Lipid were widely expected and not surprising given that two-thirds of patients in the trial would not be treated with fibrates under current guidelines," said Eugene Sun, M.D... (Source: Health News from Medical News Today)
Ranbaxy settles drug dispute with Takeda, US launch in 2012
Ranbaxy Laboratories Ltd on Monday said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the patent litigation regarding diabetic drug Actos. (Source: The Economic Times Healthcare and Biotech News)
Intensive BP, Combined Lipid Therapies Do Not Help Adults With Diabetes
Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial. Similarly, treating multiple blood lipids with combination drug therapy of a fibrate and a statin did not reduce the combined risk of cardiovascular disease events more than treatment with statin alone... (Source: Health News from Medical News Today)
More Adequate Provision Of Eye Care Services Need To 'Close The Gap' In Vision Loss In Indigenous People, Australia
Blindness rates in Indigenous Australians are still much higher than in non-Indigenous Australians, despite a probable fall in overall rates of blindness in Indigenous people in the past 30 years, according to research published in the Medical Journal of Australia. Most blindness was due to readily preventable or treatable causes of vision loss, including cataract, diabetes, refractive error and trachoma... (Source: Health News from Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Intensive BP, Combined Lipid Therapies Do Not Help Adults With Diabetes
Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial... (Source: Hypertension News From Medical News Today)
Exercising Just Got Easier For Busy People, Study Shows
If you're the type of person who invokes the "not enough time" clause when it comes to exercising, it's time to find a new excuse. Researchers who have been studying interval training have found that it not only takes less time than what is typically recommended, but the regimen does not have to be "all out" to be effective in helping reduce the risk of such diseases at Type 2 diabetes. The study appears in the March issue of The Journal of Physiology... (Source: Health News from Medical News Today)
Exercising Just Got Easier For Busy People, Study Shows
If you're the type of person who invokes the "not enough time" clause when it comes to exercising, it's time to find a new excuse. Researchers who have been studying interval training have found that it not only takes less time than what is typically recommended, but the regimen does not have to be "all out" to be effective in helping reduce the risk of such diseases at Type 2 diabetes... (Source: Diabetes News From Medical News Today)
Aggressive measures to treat diabetics make many of them worse, studies show
Rigorous treatment to bring down blood pressure and cholesterol is not beneficial and increases side effects, researchers say. It seemed like a good idea. Diabetics are at an unusually high risk of heart disease, heart attack and stroke, so sharply reducing their blood pressure, cholesterol and blood sugar should be highly beneficial. But a decade of studies of thousands of patients show that is not the case. (Source: Los Angeles Times - Science)
2 Drugs Fail to Prevent Diabetes in the Overweight
Title: 2 Drugs Fail to Prevent Diabetes in the OverweightCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Cholesterol General)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics
Title: Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 DiabeticsCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Cholesterol General)
2 Drugs Fail to Prevent Diabetes in the Overweight
Title: 2 Drugs Fail to Prevent Diabetes in the OverweightCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Heart General)
Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics
Title: Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 DiabeticsCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Heart General)
Health Tip: Symptoms of Ketoacidosis
Title: Health Tip: Symptoms of KetoacidosisCategory: Health NewsCreated: 3/12/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Diabetes General)
Start Metformin Early for Best Results
Title: Start Metformin Early for Best ResultsCategory: Health NewsCreated: 3/12/2010 2:10:00 PMLast Editorial Review: 3/15/2010 (Source: MedicineNet Diabetes General)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
2 Drugs Fail to Prevent Diabetes in the Overweight
Title: 2 Drugs Fail to Prevent Diabetes in the OverweightCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Diabetes General)
Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics
Title: Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 DiabeticsCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Diabetes General)
2 Drugs Fail to Prevent Diabetes in the Overweight
Title: 2 Drugs Fail to Prevent Diabetes in the OverweightCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Senior Health General)
Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics
Title: Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 DiabeticsCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Senior Health General)

of points, you can eat anything you want. The second phase of the diet is the longer one, because this is where the shedding happens. The number of points is raised to 20 for women and 25 for men.

The last phase of the diet begins once you’ve reached your goal and its aim is to maintain the weight achieved. This diet encourages the consumption of wholemeal pasta, wholegrain cereals, vegetables and fruits over white bread and doughnuts. Users can expect to lose up to 2 pounds a week on the average, although the first two weeks are known to cause a much more significant loss of weight. Again, this is not unique to the GI Plan, but the normal response of the body before the starvation mode kicks in.

for more information visit http://familyconfidence.com